DelSiTech
Medical Devices & Tech
Itäinen Pitkäkatu 4 B
Turku, 20520 Finland
phone: +358 2 4788 640
fax: +358 2 4788 120
Symbol Private
Founded 0
Employees
www.delsitech.com
Research Sector Medical Devices & Tech
Summary Description
Silica-based drug delivery technologies.
Management
Harry Jalonen, PhD, MBA, Member of the Board, CEO; Kai Lähdesmäki, MSc, Chairman of the Board, Vice President; Jouni Heikkilä, MD, PhD, Specialist in orthopaedics and traumatology; Antti Yli-Urpo, DDS, PhD, Member of the Board, Professor University of Turku; Gunnar Björkstén, MBA, Vice President Business Development; Matti Peltola, MD, PhD, DDS, Member of the Board; Martti Hintikka, MSc(Eng), Member of the Board, Managing Director
Keywords
drugs, delivery, injectable, implant, small molecule, proteins, polysaccharides, viruses

Comment | Printable Version | Apr. 01, 2007
If you work for DelSiTech and want to update this profile, click here


Description
DelSiTech specialises in a implant, subcutaneous and intra-muscular injectable technology for controlled release of small molecular drugs and biopharmaceuticals including proteins, polysaccharides and viruses.
Products / Services
The company operates in the development and licensing of long-term controlled drug delivery implant, subcutaneous or intramuscular formulations.
Technology / Differentiation
The DelSiTech technology, based on silica (SiO2) matrix, is flexible and applicable for synthetic small molecules but especially for labile biopharmaceuticals and for the preservation and controlled delivery of viruses.


2008-11-21-74